MedTrace Logo

Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy

NCT06398938 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2025-08-15

No results posted yet for this study

Summary

To evaluate the degree of acute and long-term intestinal, urinary and vaginal toxicity, and the impact on sexual activity of an accelerated fractionation of high dose rate interventional radiotherapy (IRT-HDR) in patients with locally advanced cervical cancer (IB2 - VA, N+/-).

Conditions

  • Locally Advanced Cervical Carcinoma

Interventions

RADIATION

Interventional Radiotherapy

The patients will undergo four IRT fractions in one week

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • VALENTINA LANCELLOTTA · Fondazione Universiataria Policlinico A Gemelli IRCCS

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-06
Primary Completion
2025-05-30
Completion
2026-12-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06398938 on ClinicalTrials.gov